Ann Dermatol.  2014 Dec;26(6):766-767. 10.5021/ad.2014.26.6.766.

Skin Sclerosis with Elevation of Serum Interleukin-6 That Is Possibly Associated with Immunoglobulin 4-Related Disease

• Motegi SI
• Uchiyama A
• Yamada K
• Uehara A
• Toki S
• Ishikawa O

• KMID: 2264879
• DOI: http://doi.org/10.5021/ad.2014.26.6.766

Abstract

No abstract available.

MeSH Terms

Immunoglobulins*
Interleukin-6*
Sclerosis*
Skin*
Immunoglobulins
Interleukin-6

Reference

1. Ikeda T, Oka M, Shimizu H, Hatakeyama M, Kanki H, Kunisada M, et al. IgG4-related skin manifestations in patients with IgG4-related disease. Eur J Dermatol. 2013; 23:241–245.

2. Miyagawa-Hayashino A, Matsumura Y, Kawakami F, Asada H, Tanioka M, Yoshizawa A, et al. High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis--is this a cutaneous manifestation of IgG4-related disease? Hum Pathol. 2009; 40:1269–1277.

3. Yamamoto T, Soejima K, Katayama I, Nishioka K. Intralesional steroid-therapy-induced reduction of plasma interleukin-6 and improvement of cutaneous plasmacytosis. Dermatology. 1995; 190:242–244.

4. Sato S, Hasegawa M, Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci. 2001; 27:140–146.

5. Khan K, Xu S, Nihtyanova S, Derrett-Smith E, Abraham D, Denton CP, et al. Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis. Ann Rheum Dis. 2012; 71:1235–1242.